| ||
  | ||
  | H.B. No. 2545 |
  | ||
  | ||
  | ||
|
||
relating to an individual's genetic data, including the use of that | ||
data by certain genetic testing companies for commercial purposes | ||
and the individual's property right in DNA; authorizing a civil | ||
penalty. | ||
       BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
       SECTION 1.  Subtitle A, Title 11, Business & Commerce Code, | ||
is amended by adding Chapter 503A to read as follows: | ||
CHAPTER 503A. DIRECT-TO-CONSUMER GENETIC TESTING COMPANIES; RIGHTS | ||
REGARDING DNA | ||
       Sec. 503A.001.  DEFINITIONS. In this chapter: | ||
             (1)  "Biological sample" means a material part of the | ||
human body, or a discharge or derivative part of the body, including | ||
tissue, blood, urine, or saliva that is known to contain DNA. | ||
             (2)  "Deidentified data" means data not reasonably | ||
linked to and that cannot reasonably be used to infer information | ||
about an identifiable individual. | ||
             (3)  "Direct-to-consumer genetic testing company" | ||
means an entity that: | ||
                   (A)  offers genetic testing products or services | ||
directly to individuals as consumers of those products or services; | ||
or | ||
                   (B)  collects, uses, or analyzes genetic data | ||
that: | ||
                         (i)  results from a direct-to-consumer | ||
genetic testing product or service; and | ||
                         (ii)  an individual rather than a health | ||
care provider provides to the entity. | ||
             (4)  "DNA" means deoxyribonucleic acid. | ||
             (5)  "Express consent" means an individual's | ||
affirmative response to a clear and meaningful notice regarding the | ||
collection, use, or disclosure of genetic data for a specific | ||
purpose. | ||
             (6)  "Genetic data" means any data, regardless of | ||
format, concerning an individual's genetic characteristics. The | ||
term: | ||
                   (A)  includes: | ||
                         (i)  raw sequence data derived from | ||
sequencing all or a portion of an individual's extracted DNA; | ||
                         (ii)  genotypic and phenotypic information | ||
obtained from analyzing an individual's raw sequence data; and | ||
                         (iii)  health information regarding the | ||
health conditions that an individual self-reports to a company and | ||
that the company: | ||
                               (a)  uses for scientific research or | ||
product development; and | ||
                               (b)  analyzes in connection with the | ||
individual's raw sequence data; and | ||
                   (B)  does not include deidentified data. | ||
             (7)  "Genetic testing" means a laboratory test of an | ||
individual's complete DNA, regions of DNA, chromosomes, genes, or | ||
gene products to determine the presence of the individual's genetic | ||
characteristics. | ||
             (8)  "Person" means an individual, partnership, | ||
corporation, association, business, or business trust or the legal | ||
representative of an organization. | ||
       Sec. 503A.002.  APPLICABILITY. (a) This chapter applies to | ||
a direct-to-consumer genetic testing company that: | ||
             (1)  offers its products or services to individuals who | ||
are residents of this state; or | ||
             (2)  collects, uses, or analyzes genetic data that: | ||
                   (A)  results from the company's products or | ||
services; and | ||
                   (B)  was provided to the company by an individual | ||
who is a resident of this state rather than by or at the direction of | ||
a health care provider. | ||
       (b)  This chapter does not apply to: | ||
             (1)  anStatutes affected: Introduced: () House Committee Report: () Engrossed: () Senate Committee Report: () Enrolled: () |